Evidence map›Paper›PMID 38787561›Full record

Trial reportJAMA network open2024

Implementation Strategies to Promote Short-Course Radiation for Bone Metastases.

Erin F Gillespie, Patricia Mae G Santos, Michael Curry, Talya Salz, Nirjhar Chakraborty, Michael Caron, Hannah E Fuchs, Nahomy Ledesma Vicioso, Noah Mathis, Rahul Kumar and 11 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Dissemination and Implementation-A Primer for Accelerating "Time to Translation" in Radiation Oncology.International journal of radiation oncology, biology, physics · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Erin F GillespieDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Patricia Mae G SantosDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Michael CurryDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Talya SalzDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Nirjhar ChakrabortyDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Michael CaronDepartment of Strategic Partnerships, Memorial Sloan Kettering Cancer Center, New York, New York.
Hannah E FuchsDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Nahomy Ledesma ViciosoDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Noah MathisDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Rahul KumarDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami.
Connor O'BrienDepartment of Radiation Oncology, Hartford HealthCare Cancer Institute, Hartford, Connecticut.
Shivani PatelDepartment of Radiation Oncology, Lehigh Valley Cancer Institute, Allentown, Pennsylvania.
David M GuttmannDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jamie S OstroffDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York.
Andrew L SalnerDepartment of Radiation Oncology, Hartford HealthCare Cancer Institute, Hartford, Connecticut.
Joseph E PanoffDepartment of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami.
Alyson F McIntoshDepartment of Radiation Oncology, Lehigh Valley Cancer Institute, Allentown, Pennsylvania.
David G PfisterDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Max VaynrubDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Jonathan T YangDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Allison Lipitz-SnydermanDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Leveraging implementation science to accelerate adoption of shorter-course radiation for breast and prostate cancerK08CA252640 · NCI · UNIVERSITY OF WASHINGTON · PI GILLESPIE, ERIN FAYE · 2020 to 2025
$1.3M
NCI NIH HHS K08 CA252640NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Importance: For patients with nonspine bone metastases, short-course radiotherapy (RT) can reduce patient burden without sacrificing clinical benefit. However, there is great variation in uptake of short-course RT across practice settings. Objective: To evaluate whether a set of 3 implementation strategies facilitates increased adoption of a consensus recommendation to treat nonspine bone metastases with short-course RT (ie, ≤5 fractions). Design, Setting, and Participants: This prospective, stepped-wedge, cluster randomized quality improvement study was conducted at 3 community-based cancer centers within an existing academic-community partnership. Rollout was initiated in 3-month increments between October 2021 and May 2022. Participants included treating physicians and patients receiving RT for nonspine bone metastases. Data analysis was performed from October 2022 to May 2023. Exposures: Three implementation strategies-(1) dissemination of published consensus guidelines, (2) personalized audit-and-feedback reports, and (3) an email-based electronic consultation platform (eConsult)-were rolled out to physicians. Main Outcomes and Measures: The primary outcome was adherence to the consensus recommendation of short-course RT for nonspine bone metastases. Mixed-effects logistic regression at the bone metastasis level was used to model associations between the exposure of physicians to the set of strategies (preimplementation vs postimplementation) and short-course RT, while accounting for patient and physician characteristics and calendar time, with a random effect for physician. Physician surveys were administered before implementation and after implementation to assess feasibility, acceptability, and appropriateness of each strategy. Results: Forty-five physicians treated 714 patients (median [IQR] age at treatment start, 67 [59-75] years; 343 women [48%]) with 838 unique nonspine bone metastases during the study period. Implementing the set of strategies was not associated with use of short-course RT (odds ratio, 0.78; 95% CI, 0.45-1.34; P = .40), with unadjusted adherence rates of 53% (444 lesions) preimplementation vs 56% (469 lesions) postimplementation; however, the adjusted odds of adherence increased with calendar time (odds ratio, 1.68; 95% CI, 1.20-2.36; P = .003). All 3 implementation strategies were perceived as being feasible, acceptable, and appropriate; only the perception of audit-and-feedback appropriateness changed before vs after implementation (19 of 29 physicians [66%] vs 27 of 30 physicians [90%]; P = .03, Fisher exact test), with 20 physicians (67%) preferring reports quarterly. Conclusions and Relevance: In this quality improvement study, a multicomponent set of implementation strategies was not associated with increased use of short-course RT within an academic-community partnership. However, practice improved with time, perhaps owing to secular trends or physician awareness of the study. Audit-and-feedback was more appropriate than anticipated. Findings support the need to investigate optimal approaches for promoting evidence-based radiation practice across settings.

Indexed as

Bone NeoplasmsQuality ImprovementAgedFemaleGuideline AdherenceHumansMaleMiddle AgedPractice Patterns, Physicians'Prospective Studies

Identifiers

PMID38787561
PMCPMC11127116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.